-
Celgene Will 'Vigorously' Defend IP Amid Report Kyle Bass Patent Challenge Could Prove Successful
Tuesday, October 27, 2015 - 2:52pm | 242Read More...Shares of Celgene Corporation(NASDAQ: CELG) on Tuesday plunged to a mid-day low of $121.41. The move came in response to a Bloomberg report the U.S. Patent & Trademark Organization may soon be reviewing a patent challenge brought on by Kyle Bass's Coalition for Affordable Drugs related to...
-
Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015
Thursday, May 7, 2015 - 5:39pm | 501Read More...It's midway through Day 3 of SALT 2015, presented by SkyBridge Capital, and a handful of publicly-traded names have been discussed by the biggest hedge fund managers on the planet. Jim Chanos Short Royal Dutch Shell, Chevron Chanos began his presentation with a slideshow covering his...
-
SALT 2015: Top Investment Ideas From Bass, Burbank, Chanos & Cooperman
Thursday, May 7, 2015 - 5:22pm | 744Read More...Some of the top investment managers in the United States presented some of their best investment themes and ideas at SALT Conference 2015 on Thursday. The panel was moderated by Omeed Malik and panelists consisted of Kyle Bass, John Burbank, Jim Chanos, Leon Cooperman and Michael Karsh. Leon...
-
Kyle Bass Challenges Biogen Fumaderm Patent
Wednesday, April 22, 2015 - 12:58pm | 164Read More...A patent held by Biogen Inc (NASDAQ: BIIB) on its Fumaderm psoriasis treatment got challenged Tuesday by hedge fund manager and short seller Kyle Bass. Fumaderm, acquired by Biogen in 2006, accounted for $62 million of Biogen's $8.2 billion in 2014 product revenue. Biogen changed hands...
-
Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent
Monday, April 20, 2015 - 4:09pm | 250Read More...Pharmacyclics, Inc. (NASDAQ: PCYC) fell victim Monday to the latest patent challenge by hedge fund manager and short seller Kyle Bass. AbbVie Inc (NYSE: ABBV) agreed last month to acquire Pharmacyclics for $21 billion. Dallas-based Hayman Capital Management L.P., managed by Bass, challenged...
-
General Motors Under The Grip Of Activists
Tuesday, February 10, 2015 - 5:10pm | 426Read More...It seems the recent upbeat results and raise in dividends by General Motors Company (NYSE: GM) were not enough to satisfy some shareholders. It was revealed on Tuesday, February 10, that four hedge funds have combined their powers to fight for a seat in the company’s board and push...
-
Kyle Bass On CNBC: General Motors Could Double Its Dividend
Friday, January 23, 2015 - 11:06am | 153Read More...Hayman Capital's Kyle Bass spoke about General Motors Company (NYSE: GM) on CNBC Friday. Bass claimed that the automaker has “too much capital on its balance sheet.” “With $27 billion in cash and doing $15 billion a year in EBITDA and...$5 or $6 billion in free cash flow,...
-
Kyle Bass Exits Facebook, Ups General Motors Holdings
Friday, November 14, 2014 - 12:28pm | 456Read More...Kyle Bass' Hayman Capital Management LP added to his position in General Motors Company (NYSE: GM) and exited Facebook Inc (NASDAQ: FB) in the third quarter. Bass, who made a fortune betting against mortgage-backed bonds in the 2008 crash, said in a quarterly regulatory filing that his...
-
Dan Loeb, Kyle Bass And Other Star Investors Love This Startup
Friday, October 31, 2014 - 12:27pm | 516Read More...Harvest, a financial discovery and communication platform, wants to take over Wall Street -- one investor at a time. The startup has already succeeded in attracting a number of well-known users, including Dan Loeb, Kyle Bass, Steve Tananbaum, Jody Lanasa and Sahm Adrangi. Numerous firms (...
-
GM Shares Resisting Constant Recall News
Tuesday, March 18, 2014 - 1:36pm | 648Read More...Despite the announcement of multiple recalls, General Motors (NYSE: GM) shares have been holding up fairly well over the last few trading sessions. In fact, after Monday's revelation of three new recalls, the issue immediately retreated $0.84 from $34.55 to $33.71, before rallying to close higher...
-
Market Wrap For March 14: Ukraine Tension Drag Markets Lower
Friday, March 14, 2014 - 5:17pm | 2348Read More...U.S. stocks declined as concerns escalated over Ukraine, two days before its citizens will vote in a referendum to split from Ukraine and become part of Russia. Russian President Vladimir Putin is gearing up to “invade eastern Ukraine” as a six hour talk between U.S. Secretary of State John...
-
Market Wrap For February 14: Markets End The Week Positive
Friday, February 14, 2014 - 5:50pm | 2701Read More...U.S. stocks rose on Friday as investors were able to overlook some disappointing economic data as a result of cold weather. Major indices showed signs of strength today as the Nasdaq continues to inch towards historical all time highs of 5,135.52 recorded on March 10,2000. Today, the index hit...
-
Bill Ackman Stands Firm, Noting, "Enron Also Had Audited Financial Statements"
Wednesday, December 18, 2013 - 10:38am | 560Read More...In late December 2012, hedge fund manager, Bill Ackman gave a 342 slide presentation explaining why he thought MLM company, Herbalife (NYSE: HLF), was an illegal pyramid scheme and why he had taken at least a 20 million share short position. Despite losing as much as $500 million over the past...
-
Market Wrap For November 4: Economy Is Steady, Tapering Could Be Around The Corner
Wednesday, December 4, 2013 - 6:16pm | 2104Read More...Stock futures declined before the equity markets opened after the ADP employment report showed a higher than expected 215,000 jobs were added during the month of November. Investors and traders were spooked by the report that solidifies the Fed's case to begin tapering. Traders and investors...
-
J.C. Penney Bulls: You Won't Like This
Tuesday, August 20, 2013 - 6:29pm | 604Read More...The miserable second-quarter release put out by struggling retailer J.C. Penney (NYSE: JCP) this morning wasn't exactly a surprise, but the sheer size of the miss has bears licking their chops. J.C. Penney reported a loss of $2.16 per share, missing earnings estimates by over 103, while also...












